Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pressure Builds On England’s HTA Body & Industry To Reduce Data Redaction

Executive Summary

The practice of redacting data from documents submitted to NICE for health technology appraisals undermines the HTA body’s role in protecting patients’ health, says the author of a study of data redaction at NICE. But the institute counters that it would not be able to publish its recommendations as quickly if confidential information could not be removed from published documents.

You may also be interested in...



Capacity Challenges Prompt NICE To Consider Secondees From Consultancy Firms

England’s health technology assessment institute is exploring solutions to help deal with its increased workload, high staff turnover and challenges in recruiting people with the expertise needed.

UK Industry Attacks Government’s ‘Unsustainable’ Repayment Proposals

Questions are being raised about the credibility of the UK’s voluntary and statutory drug pricing schemes because of uncertainty over the payment percentages companies will have to pay in future.

2021: A Record-Breaking Year For ‘Smart’ Pricing And Access Deals In England

NHS England and Improvement (NHSE&I) agreed 16 pricing and access deals with drug companies in 2021, ten of which can be considered ‘smart.’ The fact that these were achieved against a backdrop of COVID-19 is seen as impressive.

Topics

UsernamePublicRestriction

Register

PS145165

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel